Introduction {#sec1-1}
============

Epidemiology of disease changes over time with changes in socio-economic status, culture and health care systems. The changing epidemiology of a disease often provides valuable insight as to possible etiopathogenic mechanisms. When such changes take place over a relatively short interval of time, they point to the influence of exogenous factors. The past four decades have witnessed significant changes in the epidemiology of diseases of the foregut across the world.

In the adult Caucasian population of North America and Europe, a decreasing prevalence of duodenal ulcer (DU) has been noted during the last 4 decades \[[@ref1]\]. Similar observations have been made in the Asia-Pacific region of the world \[[@ref2]\]. At the same time, gastroesophageal reflux disease (GERD) has been reported to be increasing in Western countries \[[@ref3],[@ref4]\] as well as in the Asia-Pacific region \[[@ref5],[@ref6]\].

Upper gastrointestinal endoscopy is an accurate and safe method of diagnosing diseases of the esophagus, stomach and duodenum. It was introduced in a few centers in Nigeria in the 1980s and with the passage of time more health institutions have acquired the facility. There is a scarcity of published data on time trends of gastrointestinal disease in Africa. In Nigeria, no such study has been conducted. The objective of this study was to determine whether there have been any temporal changes in disease manifestations in the upper gastrointestinal (UGI) tract in Nigeria during a 15-year period.

Materials and Methods {#sec1-2}
=====================

The study was carried out at the gastrointestinal endoscopy unit of the University of Nigeria Teaching Hospital Ituku/Ozalla, Annunciation Specialist Hospital Emene and Uzoma Specialist Hospital Trans Ekulu Enugu. The endoscopy records of patients who underwent first UGI endoscopy during 2 time periods (1995 to 1999 and 2006 to 2010) were examined. For the first time period only records from the University of Nigeria Teaching Hospital were analyzed because it was the only center that provided endoscopy services during the period. For the second time period records from the three centers were analyzed.

Information extracted from the records included patients' biodata, indications for UGI endoscopy and endoscopic findings. The results are expressed as mean and proportions. Differences between means were determined using Students' t-test. The χ2 test was used to compare proportion. P value of less than 0.05 was considered statistically significant.

Results {#sec1-3}
=======

One thousand, three hundred and sixty five patients had UGI endoscopy during the two periods (575 for the period 1995 to 1999, and 790 for the period 2006 to 2010). [Table 1](#T1){ref-type="table"} shows the gender distribution of the patients. The mean age of patients in the first time period was 43.3±13.3 years while the mean age of patients in the second time period was 47.2±15.3 years. The difference between the means was not statistically significant (t=0.1347, p=0.9052). Dyspepsia accounted for 81.9% and 72.9% of indications for UGI endoscopy in the two periods. The difference between the proportions was not statistically significant (χ2=1.975, p=0.1599). Heartburn and dysphagia were significantly more frequent as indications for UGI endoscopy in the second time period compared to the first period (p\<0.0001 in each case).

###### 

Gender distribution of patients in the 2 time periods, 1995-1999 and 2006-2010
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Regarding endoscopic findings, only normal endoscopic findings, gastritis and duodenal ulcer were more frequent in the first time period compared with the second period (p=0.0019, 0.0081 and \<0.0001, respectively). The endoscopic findings that were significantly more frequent in the second time period were esophagitis (p\<0.0001), bile reflux (p=0.0019) and gastric ulcer (p=0.0007). [Table 2](#T2){ref-type="table"} illustrates a comparison of selected parameters in the 2 time periods.

###### 

Comparisons between the two time periods, 1995-1999 and 2006-2010
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Discussion {#sec1-4}
==========

For the 2 time periods, the dominant indication for UGI endoscopy remained dyspepsia. However, heartburn and dysphagia were significantly more frequent during the second time period (2006 to 2010). This is an important observation with a suggestion that diseases of the esophagus assumed greater prominence during the period. The same trend has since been reported in the western world and Asia \[[@ref3]-[@ref6]\]. Similarly, with regard to endoscopic findings, the prevalence of esophagitis increased from 8.9% in the first time period to 20.3% in the second period (P\<0.0001). GERD was previously uncommon in Asia, but has recently increased to attract public health attention \[[@ref7]\]. Similar reasons have been advanced for this observation in the two regions. These are aging population, the obesity epidemic and associated changes in diet and physical activity \[[@ref8]\].

The effect of *Helicobacter pylori* (*H. pylori*) infection of the stomach on the prevalence of GERD remains an unresolved issue. Despite the negative association observed in cross-sectional studies, the results are less consistent in longitudinal studies of *H. pylori* eradication. The conflicting observations have been linked to differences in anatomical location of gastric inflammation \[[@ref9]\], virulence of the organism \[[@ref10],[@ref11]\], and genetic characteristics of the host \[[@ref12]\]. In a meta-analysis of pooled data from 7 randomized controlled trials and 5 cohort studies comparing the prevalence of GERD among patients free from GERD at baseline with *H. pylori* eradication vs. those with persistent infection, there was no significant difference in either the risk of developing erosive or symptomatic GERD between the two groups of patients. There was no significant heterogeneity among the studies and the results were consistent in various subgroup and sensitivity analyses, suggesting high quality and consistency. Interestingly, there was a two-fold higher risk for development of erosive GERD in a subgroup of patients with peptic ulcer disease in cohort studies (odds ratio: 2.04, 95% C.I.: 1.08-3.85; p=0.03) \[[@ref13]\].

In recent years it has been recognized that *H. pylori* eradication may affect gastric secretory function other than acid secretion. The plasma level of ghrelin (an appetite stimulant produced by the gastric body) is lower in *H. pylori*-infected patients compared to healthy controls. *H. pylori* eradication leads to recovery of ghrelin secreting cells and increase in ghrelin levels \[[@ref14]-[@ref16]\]. This might increase the calorie intake and lead to weight gain, a recognized risk factor for GERD \[[@ref17],[@ref18]\].

In the case of Nigeria, there appears to be an increase in the prevalence of GERD in line with the global trend, but the explanations may not be exactly the same as in the developed world. Life expectancy cannot be said to have improved but the drift towards western diet, increasing body mass index (BMI) and obesity may explain this trend. The prevalence of obesity and obesity-related morbidities in developing countries is relatively low, but is changing rapidly \[[@ref19]-[@ref23]\].

A reduction in the prevalence of duodenal ulcer (DU) was clearly demonstrated in this study. The same trend has since been reported across the world in the last 4 decades \[[@ref1],[@ref2]\]. In the Western world and Asia the explanations that have been put forward for this trend are decreasing prevalence of *H. pylori* infection occasioned by improved hygiene and eradication of the organism from infected persons. In this study, *H. pylori* status was not part of the analysis because it was not consistently determined in the patients, and, where it was determined, various methods were used resulting in non-comparable data. However, in Nigeria, the use of proton pump inhibitors (PPIs) is indiscriminate. There are also no guidelines in place and eradication treatments are subject to abuse. Most patients would have used these drugs before presenting to the gastroenterologist. The result is that the prevalence of *H. pylori* cannot be said to be decreasing. However, the indiscriminate use of PPIs may have reduced the prevalence of DUs albeit unaltered tendency for recurrence. The status of *H. pylori* infection in Nigerian patients requires further studies.

In conjunction with the drop in the prevalence of DU over time, an increase in the prevalence of gastric ulcer (GU) is also noticed. The explanation for this may be the increasing use of non steroidal anti-inflammatory drugs (NSAIDs) for various inflammatory and painful conditions \[[@ref24]\]. Another possible explanation is the fact that the same period witnessed a rise in the prevalence of bile reflux. It is possible that patients who previously had DUs which healed as a result of the use of potent acid suppressant drugs are now left with deformities of the pylorus and duodenal cap with resultant secondary duodenogastric reflux. When bile gets into the stomach, it excites a nonspecific response which may eventuate in gastric ulcer. Similarly, gastric cancer prevalence increased from 1.2% to 2.3%. The difference was not statistically significant but may be related to several factors including duodenogastric reflux.

Esophageal cancer showed an increase in prevalence from 0.5% to 1.0% over the period under review. The increase, though not statistically significant, is a very important observation. It is possible that with time passing, the rising prevalence of GERD, the westernization of diet and ensuing obesity may lead to more cases of esophageal adenocarcinoma.

Normal endoscopic findings were more frequent in the first time period compared with the second period (p=0.0019). The reason for this may be related to the fact that current endoscopes are able to distinguish subtle mucosal abnormalities. It is also possible that the endoscopists making the assessments might have acquired more competence and experience over time.

The limitations of this study include the non inclusion of *H. pylori* infection in the analysis, the retrospective design and non standardization of the diagnosis of certain endoscopic lesions such as esophagitis. The Los Angeles (LA) classification of esophagitis which utilizes visible mucosal breaks as the minimum evidence of esophagitis is the most widely used system. Other findings such as erythema at the gastroesophageal junction or an irregular Z-line have proven not to be reliable findings for the diagnosis of reflux esophagitis \[[@ref25],[@ref26]\]. This is the basis for including grade M (minimal esophagitis) in some modified versions of the LA classification \[[@ref27]\]. A previous study in Nigeria showed a high prevalence of grade M esophagitis and a relative rarity of severe esophagitis \[[@ref28]\]. Another important limitation of this study is the fact that the patients whose records were analyzed might not have been representative of the general population since economic factors influence health-seeking behavior of patients.

In conclusion, over a 15-year period, there has been a noticeable change in disease manifestation in the UGI in Nigeria. A decline in the prevalence of DU and an increase in the prevalence of GU have been observed. There has also been an increase in the prevalence of GERD over the period. This trend may be related to widespread and indiscriminate use of potent acid suppressants, changes in diet, sedentary life style and increasing obesity.

**Summary Box**

**What is already known:**

The changing epidemiology of a disease often provides valuable insight as to possible etiopathogenic mechanismsThe past 4 decades have witnessed a decrease in the prevalence of duodenal ulcer (DU) in North America, Western Europe and AsiaThere has also been an increase in the prevalence of gastroesophageal reflux disease (GERD) over the same period in the same regions

**What the new findings are:**

During a fifteen year period in Nigeria, there have been a decrease in the prevalence of DU and an increase in the prevalence of gastric ulcerThere has also been an increase in the prevalence of GERDPossible explanations for this trend in Nigeria include widespread and indiscriminate use of acid suppressants, changes in diet, sedentary lifestyle and increasing obesity
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